European Union: CRISPR Patent Portfolio Edited: The Broad Institute Has Lost Its Appeal On A Key CRISPR Patent In Europe - Dehns

European Union: CRISPR Patent Portfolio Edited: The Broad Institute Has Lost Its Appeal On A Key CRISPR Patent In Europe - Dehns

Mondaq

Published

As I have discussed previously here, CRISPR-based techniques have revolutionized the field of gene editing in recent years.

Full Article